VYNE – vyne therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VYNE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/2

08:32 am

vyne

Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders

Medium Report

Halper Sadeh LLC is Investigating Whether APLS, CNTA, EQH, VYNE are Obtaining Fair Deals for their Shareholders

Report

4/1

02:06 pm

vyne

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN

Low Report

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN

Report

2/2

01:31 am

vyne

VYNE Therapeutics (NASDAQ:VYNE) was upgraded by analysts at Wall Street

Low Report

VYNE Therapeutics (NASDAQ:VYNE) was upgraded by analysts at Wall Street

Report

1/25

03:05 am

vyne

VYNE Therapeutics (NASDAQ:VYNE) was downgraded by analysts at Wall Stree

Low Report

VYNE Therapeutics (NASDAQ:VYNE) was downgraded by analysts at Wall Stree

Report

1/23

05:09 am

vyne

VYNE Therapeutics (NASDAQ:VYNE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

VYNE Therapeutics (NASDAQ:VYNE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.